tirzepatide injection site itching Tirzepatide-Induced Reaction Mounjaro injection site reaction?

FLOW trial of Semaglutide, source: Novo Nordisk official website The key objective of the FLOW trial is to demonstrate delay in progression of CKD and to lower the risk of kidney and cardiovascular mortality through the composite primary endpoint consisting of the following five components: compared with baseline: 1) sustained decrease in eGFR1 50%

Funding: This study was funded by the National Institutes of Healths (NIH) National Institute of Diabetes and Digestive and Kidney Diseases

It is therefore important to drink plenty of fluids to prevent dehydration

No diagnosis or prior treatment history is required

Some patients may experience gastrointestinal side effects like nausea and diarrhea that could impact their ability to maintain proper nutrition and hydration

Additionally, it improves insulin sensitivity, making it particularly beneficial for individuals with type 2 diabetes or those at risk of developing this condition